Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Otter Tail Corporation | OT4 | Nov 15, 2024 | 75.50 | 0.00 |
Otto Energy Ltd. | O1E | Nov 15, 2024 | 0.00 | 0.00 |
OUE Limited | OUE1 | Nov 15, 2024 | 0.69 | 0.00 |
Ourgame International Holdings Limited | 13O | Nov 15, 2024 | 0.02 | 0.00 |
Outbrain Inc | 852 | Nov 15, 2024 | 4.76 | -4.80 |
Outfront Media Inc | 76C | Nov 15, 2024 | 17.00 | -3.95 |
Outlook Therapeutics | 41O | Nov 15, 2024 | 5.10 | -8.11 |
Outokumpu | OUTA | Nov 15, 2024 | 3.21 | -0.34 |
OUTSURANCE GROUP LTD. | RMQ0 | Nov 15, 2024 | 3.12 | +0.65 |
Ovation Science Inc Common Shares (Canada) | 0VH | Nov 15, 2024 | 0.01 | 0.00 |
Ovb Holding | O4B | Nov 15, 2024 | 19.20 | -0.52 |
Oversea-chinese Banking Corp | OCBB | Nov 15, 2024 | 23.00 | +0.88 |
Oversea-Chinese Banking Corporation Limited | OCBA | Nov 15, 2024 | 11.55 | -1.41 |
Overstock.com, Inc. | OVER | Nov 15, 2024 | 5.56 | -0.82 |
OVH Groupe | 7U7 | Nov 15, 2024 | 8.30 | +0.30 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | Nov 15, 2024 | 3.60 | -0.55 |
Ovid Therapeutics Inc. | 1OT | Nov 15, 2024 | 0.95 | -14.73 |
Ovintiv Inc. (DE) | 47Q | Nov 15, 2024 | 41.98 | +5.66 |
Ovs SPA | 0OV1 | Nov 15, 2024 | 2.87 | -0.21 |
Ovzon | OVZ | Nov 15, 2024 | 1.14 | +25.83 |
Owens & Minor, Inc. | 6OM | Nov 15, 2024 | 11.50 | +1.77 |
Owens Corning Inc | O5Q | Nov 15, 2024 | 180.60 | -1.98 |
Owl Rock Capital Corporation | 1D6 | Nov 15, 2024 | 14.12 | +0.36 |
OXE Marine | 5LK | Nov 15, 2024 | 0.01 | +2.13 |
Oxford BioDynamics plc | LMQ | Nov 15, 2024 | 0.00 | 0.00 |
Oxford Biomedica | OXOA | Nov 15, 2024 | 4.76 | -1.24 |
Oxford Industries, Inc. | OXD | Nov 15, 2024 | 72.50 | +0.69 |
Oxford Instruments PLC | OX3 | Nov 15, 2024 | 24.60 | +0.82 |
Oxford Lane Capital Corp. | 4RQ | Nov 15, 2024 | 4.95 | -2.56 |
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred | 4RQ0 | Nov 15, 2024 | 22.40 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.